Switching of H2-receptor antagonists to over-the-counter status in Finland: Implications for consumption and adverse effects

Clinical Drug Investigation

Volumn 25, Issue 4, 2005, Pages 243-248

  Närhi, Ulla ^a   Vanakoski, Jyrki ^a   Sihvo, Sinikka ^b  

^a NATIONAL AGENCY FOR MEDICINES   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALUMINUM; ANTACID AGENT; CALCIUM; ESOMEPRAZOLE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MAGNESIUM; NON PRESCRIPTION DRUG; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; SUCRALFATE;

AGRANULOCYTOSIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; DERMOGRAPHISM; DRUG CHOICE; DRUG MARKETING; DRUG SAFETY; DRUG USE; ECZEMA; EPIDERMOLYSIS; ERYTHEMA; EVALUATION; FEVER; FINLAND; FLUSHING; GASTROESOPHAGEAL REFLUX; HEPATITIS; HISTAMINE RELEASE; HUMAN; PEPTIC ULCER; PHOTOSENSITIVITY DISORDER; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; RASH; SELF MEDICATION; SIDE EFFECT; URTICARIA;

EID: 17844400047     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200525040-00003     Document Type: Article

References (10)

1. Sihvo S, Hemminki E. Self-medication of dyspepsia: how appropriate is it? Scand J Gastroenterol 1997; 32: 855-61
2. National Agency for Medicines and Social Insurance Institution. Finnish Statistics on Medicines, Edita, Helsinki, Finland 1993-2003
3. WHO Collaborating Centre for Drug Statistics. Guidelines for ATC classification and DDD assignment. Oslo, Norway: WHO Collaborating Centre for Drug Statistics, 2003
4. The National Agency for Medicines. Reporting adverse drug reactions: the guidelines of the National Agency for Medicines 4/2001. Helsinki, Finland: The National Agency for Medicines, 2001
5. Apoteket AB. Svensk Läkemedelsstatistik 1996-2002. Stockholm, Sweden: Apoteket AB, 2002
6. Norsk Medisinaldepot ASA. Drug consumption in Norway 1997-2002. Oslo, Norway: Norsk Medisinaldepot ASA, 2002
7. Kalsta K, Voipio T, Palva E. Consumption of ulcer drugs, were there any changes following the switch of H2 receptor antagonists to over-the-counter status? TABU, Drug Information from the National Agency for Medicines, Finland 1997; 3: 45-46
8. 2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status. Pharmacol Toxicol 1991; 69: 253-258
9. 2-blocker in Sweden. J Soc Admin Pharm 2001; 18: 35-40
10. Karttunen P, Holttinen K, Juntunen T, et al. The manual for pharmacies (in Finnish). Helsinki: Pharmapress Oy, 2001